← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 26, 2017Last known activity
Jun 30, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 2 (5 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05342012Lead sponsorN/AJun 30, 2022
- NCT03727386Lead sponsorN/AJun 19, 2019
- NCT03228550Reponsible party - principal investigatorPhase 2Feb 26, 2017
- NCT03228550Overall official - principal investigatorPhase 2Feb 26, 2017
- NCT03228550Study directorPhase 2Feb 26, 2017
- NCT03228550Lead sponsorPhase 2Feb 26, 2017
Details
- Last known activity
- Jun 30, 2022